次世代オンコロジーデバイス＆ソリューション市場：コンポーネント、がんタイプ、エンドユーザー別-2025-2030年の世界予測

次世代オンコロジーデバイス＆ソリューション市場は、2023年に156億2,000万米ドルと評価され、2024年には189億7,000万米ドルに達すると予測され、CAGR 21.15％で成長し、2030年には598億4,000万米ドルに達すると予測されています。

次世代腫瘍学機器とソリューションの範囲と定義には、がんをより効果的に診断、監視、治療するために開発された高度な技術と方法が含まれます。精密医療と個別化治療アプローチを中核とするこれらの技術革新は、分子診断、AI主導の分析、低侵襲手術ツールを活用しています。その必要性は、がん罹患率の増加や、早期発見とオーダーメイド治療計画の精度向上に対する緊急のニーズから生じています。治療用途はさまざまな種類のがんにまたがり、最終用途環境には診断ラボ、病院、がん専門治療センターなどが含まれます。市場の洞察によると、主な成長要因には、画像処理とAIの技術進歩、ヘルスケア支出の増加、がんの早期診断に関する意識の高まりが含まれます。潜在的なビジネスチャンスは、がん治療のための遠隔医療ソリューションの拡大にあり、最先端の治療への患者のアクセスを劇的に改善する可能性があります。さらに、ハイテク企業との連携を強化することで、治療効果をリアルタイムでモニタリングするためのAI搭載プラットフォームの開発を推進できます。しかし、研究開発コストの高さ、厳しい規制当局の承認、データ・プライバシーに関する懸念など、市場拡大の妨げとなる課題も残っています。また、これらの機器を既存のインフラに組み込む際の制限も大きな障壁となっています。イノベーションは、継続的モニタリングのためのウェアラブル技術、データシステムの相互運用性の向上、機械学習による精密医療モデルの改良に焦点を当てるべきです。統合的ながん治療ソリューションを育成するために、バイオテクノロジー企業や製薬企業との提携を優先させることで、事業の成長が促進される可能性があります。市場は本質的にダイナミックであり、急速な技術進化や規制状況の影響を受けるため、持続的成長のためには適応戦略が必要となります。研究開発への積極的な投資と戦略的提携は現在の技術的ギャップを埋めることができ、政策提言は規制上の制約を緩和することができます。患者コミュニティと積極的に関わり、現実のニーズを理解することで、ユーザー中心の製品開発が促進され、採用率と市場浸透が高まると思われます。

市場力学：急速に進化する次世代オンコロジーデバイス＆ソリューション市場の主要市場インサイトを公開

次世代オンコロジーデバイス＆ソリューション市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界のがん罹患率の増加
  • 診断および治療における低侵襲技術への嗜好の高まり
  • ヘルスケアインフラを改善するための政府の取り組み
• 市場抑制要因
  • 次世代機器製造のための高額な初期投資
• 市場機会
  • 進行中の腫瘍学検査・治療技術の進歩
  • 個別化医療と先進ゲノム医療の普及
• 市場の課題
  • 診断の標準化が不十分であるという懸念

ポーターのファイブフォース：次世代オンコロジーデバイス＆ソリューション市場をナビゲートする戦略ツール

ポーターのファイブフォース」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：次世代オンコロジーデバイス＆ソリューション市場における外部からの影響の把握

外部マクロ環境要因は、次世代オンコロジーデバイス＆ソリューション市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析次世代オンコロジーデバイス＆ソリューション市場における競合情勢の把握

次世代オンコロジーデバイス＆ソリューション市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス次世代オンコロジーデバイス＆ソリューション市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、次世代オンコロジーデバイス＆ソリューション市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨次世代オンコロジーデバイス＆ソリューション市場における成功への道筋を描く

次世代オンコロジーデバイス＆ソリューション市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中でがんの罹患率が増加
    • 低侵襲診断および治療技術の好感度の高まり
    • ヘルスケアインフラ改善に向けた政府の取り組み
  • 抑制要因
    • 次世代デバイスの製造のための高額な初期投資
  • 機会
    • 腫瘍学の検査と治療継続的な技術進歩
    • 個別化医療と先端ゲノム医療の普及
  • 課題
    • 診断の不十分な標準化に関連する懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 次世代オンコロジーデバイス＆ソリューション市場：コンポーネント別

• デバイス
  • 放射線治療の高度な形態
  • 高強度焦点式超音波
• ソフトウェア

第7章 次世代オンコロジーデバイス＆ソリューション市場がんの種類別

• 乳がん
• 子宮頸がん
• 大腸がん
• 肺がん

第8章 次世代オンコロジーデバイス＆ソリューション市場：エンドユーザー別

• 画像診断センター
• 病院

第9章 南北アメリカの次世代オンコロジーデバイス＆ソリューション市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の次世代オンコロジーデバイス＆ソリューション市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの次世代オンコロジーデバイス＆ソリューション市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Brainlab
• Danaher Corporation
• Exact Sciences Corp.
• F. Hoffmann-La Roche Ltd.
• GE HealthCare Technologies, Inc.
• Guardant Health Inc.
• Hologic, Inc.
• Illumina, Inc.
• Johnson & Johnson Services Inc.
• Merck & Co., Inc.
• Myriad Genetics, Inc.
• NanoString Technologies, Inc.
• Natera, Inc.
• NeoGenomics, Inc.
• Novartis AG
• Paige.AI, Inc.
• PerkinElmer, Inc.
• QIAGEN N.V.
• Quest Diagnostics Incorporated
• Royal Philips
• Siemens AG
• Sysmex Corporation
• Takara Bio USA, Inc.
• Thermo Fisher Scientific Inc.
• Veracyte, Inc.

LIST OF FIGURES

• FIGURE 1. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET RESEARCH PROCESS
• FIGURE 2. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET DYNAMICS
• TABLE 7. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY ADVANCED FORMS OF RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. CANADA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 35. CANADA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 36. CANADA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 37. CANADA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. CHINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 57. CHINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 58. CHINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 59. CHINA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. INDIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 61. INDIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 62. INDIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 63. INDIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. ITALY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 130. ITALY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 131. ITALY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 132. ITALY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. POLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 146. POLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 147. POLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 148. POLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. QATAR NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 150. QATAR NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 151. QATAR NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 152. QATAR NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 189. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 190. NEXT-GENERATION ONCOLOGY DEVICES & SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023

The Next-Generation Oncology Devices & Solutions Market was valued at USD 15.62 billion in 2023, expected to reach USD 18.97 billion in 2024, and is projected to grow at a CAGR of 21.15%, to USD 59.84 billion by 2030.

The scope and definition of next-generation oncology devices and solutions encompass advanced technologies and methods developed to diagnose, monitor, and treat cancer more effectively. With precision medicine and personalized treatment approaches at the core, these innovations leverage molecular diagnostics, AI-driven analytics, and minimally invasive surgical tools. The necessity arises from the increasing cancer prevalence and the urgent need for enhanced accuracy in early detection and tailored treatment plans. Applications span across various types of cancers, and end-use environments include diagnostic labs, hospitals, and specialized cancer treatment centers. Market insights reveal that key growth factors include technological advancements in imaging and AI, rising healthcare expenditures, and increasing awareness regarding early cancer diagnosis. Potential opportunities lie in expanding telemedicine solutions for cancer care, which could drastically improve patient accessibility to cutting-edge treatments. Furthermore, enhancing collaboration with tech firms can drive the development of AI-powered platforms for real-time monitoring of treatment efficacy. However, challenges persist, such as high R&D costs, stringent regulatory approvals, and data privacy concerns, which can hinder market expansion. Limitations in integrating these devices within existing infrastructure also pose significant barriers. Innovation should focus on wearable tech for continuous monitoring, improving interoperability of data systems, and refining precision medicine models through machine learning. Business growth could be fueled by prioritizing partnerships with biotech and pharma companies to foster integrated cancer care solutions. The market is inherently dynamic, influenced by rapid technological evolution and regulatory landscapes, necessitating adaptive strategies for sustained growth. Robust investments in R&D and strategic collaborations can bridge current technological gaps, while policy advocacy could ease regulatory constraints. Active engagement with patient communities to understand real-world needs will drive user-centric product development, enhancing adoption rates and market penetration.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Next-Generation Oncology Devices & Solutions Market

The Next-Generation Oncology Devices & Solutions Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of cancer across the globe
  • Rising preference for minimally invasive techniques of diagnosis and treatment
  • Government Initiatives to improve healthcare infrastructure
• Market Restraints
  • High initial investments for manufacturing of next generation devices
• Market Opportunities
  • Ongoing technological advancements oncology testing and treatment
  • Proliferation of personalized and advanced genome medicine
• Market Challenges
  • Concern associated with the insufficient standardization of diagnostics

Porter's Five Forces: A Strategic Tool for Navigating the Next-Generation Oncology Devices & Solutions Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Next-Generation Oncology Devices & Solutions Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Next-Generation Oncology Devices & Solutions Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Next-Generation Oncology Devices & Solutions Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Next-Generation Oncology Devices & Solutions Market

A detailed market share analysis in the Next-Generation Oncology Devices & Solutions Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Next-Generation Oncology Devices & Solutions Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Next-Generation Oncology Devices & Solutions Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Next-Generation Oncology Devices & Solutions Market

A strategic analysis of the Next-Generation Oncology Devices & Solutions Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Next-Generation Oncology Devices & Solutions Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Brainlab, Danaher Corporation, Exact Sciences Corp., F. Hoffmann-La Roche Ltd., GE HealthCare Technologies, Inc., Guardant Health Inc., Hologic, Inc., Illumina, Inc., Johnson & Johnson Services Inc., Merck & Co., Inc., Myriad Genetics, Inc., NanoString Technologies, Inc., Natera, Inc., NeoGenomics, Inc., Novartis AG, Paige.AI, Inc., PerkinElmer, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Royal Philips, Siemens AG, Sysmex Corporation, Takara Bio USA, Inc., Thermo Fisher Scientific Inc., and Veracyte, Inc..

Market Segmentation & Coverage

This research report categorizes the Next-Generation Oncology Devices & Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Component, market is studied across Devices and Software. The Devices is further studied across Advanced Forms of Radiation Therapy and High-Intensity Focused Ultrasound.
• Based on Cancer Type, market is studied across Breast Cancer, Cervical Cancer, Colorectal Cancer, and Lung Cancer.
• Based on End User, market is studied across Diagnostic Imaging Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of cancer across the globe
    • 5.1.1.2. Rising preference for minimally invasive techniques of diagnosis and treatment
    • 5.1.1.3. Government Initiatives to improve healthcare infrastructure
  • 5.1.2. Restraints
    • 5.1.2.1. High initial investments for manufacturing of next generation devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing technological advancements oncology testing and treatment
    • 5.1.3.2. Proliferation of personalized and advanced genome medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Concern associated with the insufficient standardization of diagnostics
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Next-Generation Oncology Devices & Solutions Market, by Component

• 6.1. Introduction
• 6.2. Devices
  • 6.2.1. Advanced Forms of Radiation Therapy
  • 6.2.2. High-Intensity Focused Ultrasound
• 6.3. Software

7. Next-Generation Oncology Devices & Solutions Market, by Cancer Type

• 7.1. Introduction
• 7.2. Breast Cancer
• 7.3. Cervical Cancer
• 7.4. Colorectal Cancer
• 7.5. Lung Cancer

8. Next-Generation Oncology Devices & Solutions Market, by End User

• 8.1. Introduction
• 8.2. Diagnostic Imaging Centers
• 8.3. Hospitals

9. Americas Next-Generation Oncology Devices & Solutions Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Next-Generation Oncology Devices & Solutions Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Next-Generation Oncology Devices & Solutions Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Agilent Technologies, Inc.
• 3. Bio-Rad Laboratories, Inc.
• 4. Brainlab
• 5. Danaher Corporation
• 6. Exact Sciences Corp.
• 7. F. Hoffmann-La Roche Ltd.
• 8. GE HealthCare Technologies, Inc.
• 9. Guardant Health Inc.
• 10. Hologic, Inc.
• 11. Illumina, Inc.
• 12. Johnson & Johnson Services Inc.
• 13. Merck & Co., Inc.
• 14. Myriad Genetics, Inc.
• 15. NanoString Technologies, Inc.
• 16. Natera, Inc.
• 17. NeoGenomics, Inc.
• 18. Novartis AG
• 19. Paige.AI, Inc.
• 20. PerkinElmer, Inc.
• 21. QIAGEN N.V.
• 22. Quest Diagnostics Incorporated
• 23. Royal Philips
• 24. Siemens AG
• 25. Sysmex Corporation
• 26. Takara Bio USA, Inc.
• 27. Thermo Fisher Scientific Inc.
• 28. Veracyte, Inc.